Guardant Health, Inc. (GH) stock
GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$154.86+0.08 (+0.05%)
Close on Nov 12, 2026Market cap $20.78BP/E –Yield –
Guardant Health operating margin
Operating margin is operating income as a percentage of revenue.
Guardant Health's operating margin for the twelve months ending Sep 30, 2026 was -39.4%. For fiscal 2025 it was -44.5%, against -60.0% the year before. The highest annual figure on record is -38.4% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -44.5% | +15.5 |
| FY2024 | Dec 31, 2024 | -60.0% | +40.1 |
| FY2023 | Dec 31, 2023 | -100.1% | +21.0 |
| FY2022 | Dec 31, 2022 | -121.1% | −11.1 |
| FY2021 | Dec 31, 2021 | -110.0% | −21.1 |
| FY2020 | Dec 31, 2020 | -88.9% | −50.5 |
| FY2019 | Dec 31, 2019 | -38.4% | +64.1 |
| FY2018 | Dec 31, 2018 | -102.5% | +51.2 |
| FY2017 | Dec 31, 2017 | -153.7% | +19.9 |
| FY2016 | Dec 31, 2016 | -173.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -36.8% | +0.5 |
| Q2 FY2026 | Jun 30, 2026 | -38.5% | +7.3 |
| Q1 FY2026 | Mar 31, 2026 | -40.2% | +14.3 |
| Q4 FY2025 | Dec 31, 2025 | -43.0% | +19.5 |
| Q3 FY2025 | Sep 30, 2025 | -37.3% | +23.9 |
| Q2 FY2025 | Jun 30, 2025 | -45.9% | +10.9 |
| Q1 FY2025 | Mar 31, 2025 | -54.6% | +4.6 |
| Q4 FY2024 | Dec 31, 2024 | -62.4% | +65.0 |
| Q3 FY2024 | Sep 30, 2024 | -61.3% | +18.1 |
| Q2 FY2024 | Jun 30, 2024 | -56.8% | +30.4 |
| Q1 FY2024 | Mar 31, 2024 | -59.2% | +45.0 |
| Q4 FY2023 | Dec 31, 2023 | -127.4% | −12.2 |
| Q3 FY2023 | Sep 30, 2023 | -79.4% | +43.8 |
| Q2 FY2023 | Jun 30, 2023 | -87.2% | +32.2 |
| Q1 FY2023 | Mar 31, 2023 | -104.1% | +24.2 |
| Q4 FY2022 | Dec 31, 2022 | -115.2% | −24.3 |
| Q3 FY2022 | Sep 30, 2022 | -123.2% | −10.0 |
| Q2 FY2022 | Jun 30, 2022 | -119.4% | −13.4 |
| Q1 FY2022 | Mar 31, 2022 | -128.3% | +8.8 |
| Q4 FY2021 | Dec 31, 2021 | -90.8% | +25.6 |
| Q3 FY2021 | Sep 30, 2021 | -113.2% | −13.6 |
| Q2 FY2021 | Jun 30, 2021 | -106.0% | −23.7 |
| Q1 FY2021 | Mar 31, 2021 | -137.1% | −85.4 |
| Q4 FY2020 | Dec 31, 2020 | -116.4% | −75.1 |
| Q3 FY2020 | Sep 30, 2020 | -99.6% | −70.9 |
| Q2 FY2020 | Jun 30, 2020 | -82.3% | −54.1 |
| Q1 FY2020 | Mar 31, 2020 | -51.7% | +12.8 |
| Q4 FY2019 | Dec 31, 2019 | -41.3% | +42.0 |
| Q3 FY2019 | Sep 30, 2019 | -28.7% | +82.9 |
| Q2 FY2019 | Jun 30, 2019 | -28.3% | +88.8 |
| Q1 FY2019 | Mar 31, 2019 | -64.6% | +47.2 |
| Q4 FY2018 | Dec 31, 2018 | -83.3% | −5.2 |
| Q3 FY2018 | Sep 30, 2018 | -111.6% | +146.0 |
| Q2 FY2018 | Jun 30, 2018 | -117.1% | – |
| Q1 FY2018 | Mar 31, 2018 | -111.7% | – |
| Q4 FY2017 | Dec 31, 2017 | -78.1% | – |
| Q3 FY2017 | Sep 30, 2017 | -257.6% | – |
See a number that looks wrong?